about
Systemic biomarkers of neutrophilic inflammation, tissue injury and repair in COPD patients with differing levels of disease severityPotential prognostic value of biomarkers in lavage, sputum and serum in a five year clinical follow-up of smokers with and without COPDAngiopoietin-like protein 4 and cardiovascular function in COPD.Physical activity patterns and clusters in 1001 patients with COPD.Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.Disease Progression and Changes in Physical Activity in Patients with Chronic Obstructive Pulmonary Disease.Lactate dehydrogenase as prognostic factor in limited and extensive disease stage small cell lung cancer - a retrospective single institution analysis.Hyponatremia as prognostic factor in small cell lung cancer--a retrospective single institution analysis.Physical Activity and Fatigue in Patients with Sarcoidosis.Clinical Correlates of Reduced Physical Activity in Idiopathic Pulmonary Fibrosis.Characteristics, treatment patterns and outcomes of patients with small cell lung cancer--a retrospective single institution analysis.Reduced physical activity in lymphangioleiomyomatosis compared with COPD and healthy controls: disease-specific impact and clinical correlates.[Measurement of physical activity in patients with chronic obstructive pulmonary disease].Neutrophil extracellular trap formation and extracellular DNA in sputum of stable COPD patients.Airway obstruction and lung hyperinflation in COPD are linked to an impaired left ventricular diastolic filling.Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study.Physical activity in patients with COPD.Physical activity, airway resistance and small airway dysfunction in severe asthma.The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity.Right Ventricular Index for Risk Stratification of Patients with Pulmonary Arterial HypertensionBiomarkers and clinical outcomes in COPD: a systematic review and meta-analysis[Heart failure in chronic obstructive pulmonary disease (COPD)]Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter studyDecreasing cardiac chamber sizes and associated heart dysfunction in COPD: role of hyperinflation[Analysis of treatment outcomes in two patient cohorts (2004-2005 and 2007-2008) with limited and extensive disease small-cell lung cancer]Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort studyHandgrip weakness and mortality risk in COPD: a multicentre analysisPrevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohortHigh-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study
P50
Q28728578-44453E57-A9C2-4336-9E7F-E7FAB970EA3BQ33612752-BECCDBF4-91CC-4CF9-8EBE-B35A981B777CQ37464058-DE48FDB4-7776-41E7-8A87-B6B4737490B2Q38642968-6F333F0B-8C0F-4CFF-BCEC-B2DF7C9D4EB9Q38661833-A34BCF09-1B95-4438-AD14-7705052E3090Q41711651-853541F3-0359-4BB2-8537-BD294A675757Q42933797-24A06A7A-53B2-4079-8827-700A2AC3858AQ44484991-FED19C95-AA80-4EE7-9923-4D5759B82383Q47713859-CA24629C-2225-4ACC-B021-50F8FD666365Q47736937-180A3612-C957-4DA5-AA01-38237BA71EC5Q48133713-539EBFAF-4C6B-45AE-82EB-3AF1F92B54EEQ50920584-CFAB0059-83E2-43DC-B971-2FC435FE96F7Q51131482-89D5D0FC-2C4E-4226-A1FD-C638F141BE77Q51599504-AFE73C02-F240-4391-B053-B7C9EB745C6AQ51731597-C4173AF6-C81F-419D-8DD2-8ED77ABE4A38Q51896643-68D2AC24-928B-4309-95C6-81C5FBF676BBQ53124508-172E5107-1A48-40EB-9183-2CD67DF61F66Q53755162-57C2B629-7669-421D-B2CA-6E0EE7E437BCQ53951321-D1D647F6-FD9E-4E81-B452-0FD2926CD529Q60211286-CD7FCA11-8C0F-4968-9BBE-F57C0E02031EQ64235328-331A2B96-9130-46BE-9872-7F5796926D17Q80945643-72B57DB7-F178-4704-A0A4-E6EDE4B2DF91Q82687739-571B255D-B3EC-46BC-86A6-1A26D472973DQ83067910-62A49B57-6CEC-45E2-B32B-D217E55B2CE0Q83299778-3D55C5EC-C43A-4E3D-9D8A-B12B3C4DAA9AQ83313267-157DEDA2-B83D-4D8E-9E10-F47C71A7B0DBQ86582209-B12227A1-0506-4721-9F05-E364975D4475Q90397438-58EB9701-A152-4325-97C0-16FD556D9F45Q91930848-B069E160-44B1-4A8F-917A-EA6B4985F0E5
P50
description
researcher ORCID ID = 0000-0002-1070-3661
@en
wetenschapper
@nl
name
Benjamin Waschki
@ast
Benjamin Waschki
@en
Benjamin Waschki
@es
Benjamin Waschki
@nl
type
label
Benjamin Waschki
@ast
Benjamin Waschki
@en
Benjamin Waschki
@es
Benjamin Waschki
@nl
prefLabel
Benjamin Waschki
@ast
Benjamin Waschki
@en
Benjamin Waschki
@es
Benjamin Waschki
@nl
P1153
23987158800
P31
P496
0000-0002-1070-3661